ESR1 and neoplasm: Evidence that genetic factors can also influence tumor type is provided by the fact that carriers of highly penetrant mutations in BRCA1 are more likely to be diagnosed with basal breast tumors which are estrogen receptor (ER) negative, progesterone receptor (PR) negative and HER2 negative [5].